Archive for: February 2008

HealthDay - TUESDAY, Feb. 26 (HealthDay News) -- Men considering prostate cancer screening who used an interactive Web-based, decision-making tool knew more about the disease and were less likely to choose screening than men who got information from credible Web sites, a U.S. study concludes.

Reuters - Men who want to avoid developing the benign but bothersome prostate enlargement that typically accompanies aging should cut their intake of fat and red meat, eat more vegetables, and have a couple of drinks a day, a new study suggests.

HealthDay - FRIDAY, Feb. 22 (HealthDay News) -- The U.S. Food and Drug Administration went against the recommendation of its own advisory panel on Friday and approved the cancer drug Avastin for women with advanced breast cancer.

Reuters - Working in a job that requires a continuous level of high physical effort may decrease the likelihood of a man developing prostate cancer, researchers report.

HealthDay - WEDNESDAY, Feb. 13 (HealthDay News) -- One of the largest studies of its kind concludes that most older men with early prostate cancer do not shorten their survival odds if they adopt a "wait-and-see" approach to the disease.

Reuters - An experimental vaccine can provide long-term protection against prostate cancer in mice genetically predisposed to the disease, new research indicates.

Reuters - Genentech Inc said on Tuesday its cancer drug, Avastin, met the primary goal of prolonging progression-free survival when combined with chemotherapy in a breast cancer study, sending its shares up more than 3 percent.

HealthDay - MONDAY, Feb. 11 (HealthDay News) -- Scientists have uncovered at least 10 new genetic variations associated with an increased risk for prostate cancer.

AFP - Gene sleuths have identified more than 10 new genetic links to prostate cancer, two of which would be included in a new diagnostic test aimed at spotting men at risk from this disease.

AFP - Gene sleuths on Sunday announced they had identified more than 10 new genetic links to prostate cancer, two of which would be included in a new diagnostic test aimed at spotting men at risk from this disease.